<?xml version="1.0" encoding="iso-8859-1"?>
<rss version="2.0"><channel><title>Individual feed for https://www.medscape.com/cx/rssfeeds/2700.xml</title><link>https://www.medscape.com/cx/rssfeeds/2700.xml</link><description>Individual feed output.</description><lastBuildDate>Sun, 07 Sep 2025 22:38:41 GMT</lastBuildDate><generator>PyRSS2Gen-1.1.0</generator><docs>http://blogs.law.harvard.edu/tech/rss</docs><item><title>First-Line Osimertinib Plus Chemo Extends Survival in NSCLC</title><link>https://www.medscape.com/viewarticle/first-line-osimertinib-plus-chemo-extends-survival-nsclc-2025a1000nll?src=rss</link><image_url>https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture6.png</image_url><description>The FLAURA2 trial establishes a new standard of care for EGFR-mutated NSCLC, according to the authors of new research. Medscape Medical News</description><pubDate>Mon, 08 Sep 2025 01:28:36 GMT</pubDate></item><item><title>NSCLC Survival Benefit Seen With EGFR-TKI + Chemo</title><link>https://www.medscape.com/viewarticle/nsclc-survival-benefit-seen-egfr-tki-chemo-2025a1000nlj?src=rss</link><image_url>https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture9.png</image_url><description>Median PFS benefit was just over 3 months in patients with EGFR-mutant NSCLC who had tumor suppressor gene co-mutations. Medscape Medical News</description><pubDate>Mon, 08 Sep 2025 00:35:35 GMT</pubDate></item><item><title>Osimertinib's Benefits in NSCLC Can Extend Beyond First Line</title><link>https://www.medscape.com/viewarticle/osimertinibs-benefits-nsclc-can-extend-beyond-first-line-2025a1000nlc?src=rss</link><image_url>https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture3.png</image_url><description>Patients with EGFR-mutated NSCLC who progress on first-line osimertinib live longer without disease worsening when the drug is maintained alongside ch...</description><pubDate>Sun, 07 Sep 2025 20:20:16 GMT</pubDate></item><item><title>Perioperative Nivolumab Does Not Sacrifice QoL in NSCLC</title><link>https://www.medscape.com/viewarticle/perioperative-nivolumab-does-not-sacrifice-qol-nsclc-2025a1000nl9?src=rss</link><image_url>https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture3.png</image_url><description>Perioperative nivolumab in eligible patients with resectable non-small cell lung cancer offers improved survival outcomes and preserves quality of lif...</description><pubDate>Sun, 07 Sep 2025 16:31:52 GMT</pubDate></item><item><title>Does Eating Red Meat Actually Raise Your Cancer Risk?</title><link>https://www.medscape.com/s/viewarticle/does-eating-red-meat-actually-raise-your-cancer-risk-2025a1000nj6?src=rss</link><image_url>https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture7.png</image_url><description>Daily processed meat consumption slightly increases colon cancer risk, but occasional consumption is far less concerning than headlines suggest. Medsc...</description><pubDate>Fri, 05 Sep 2025 18:41:08 GMT</pubDate></item></channel></rss>